The Antibody Drug Conjugates (ADC) Market revolves around a class of biopharmaceuticals designed to target and destroy cancer cells. ADCs are composed of an antibody, which specifically binds to cancer cells, a cytotoxic (cell-killing) agent, and a linker that connects the two. By combining the targeting ability of monoclonal antibodies with the potent cancer-killing effects of chemot... https://linkewire.com/2024/10/14/antibody-drug-conjugates-adc-market-pioneering-targeted-cancer-therapies-up-to-2033/